## Synthesis
- 
## Source [^1]
- $n$. an inhibitor of multiple kinases (see PROTEIN KINASE; TYROSINE KINASE INHIBITOR) that blocks the action of vascular endothelial growth factor. It is used for the treatment of advanced renal cell carcinoma and of gastrointestinal stromal tumour after disease progression or on intolerance to imatinib. Its most common side-effects include fatigue, asthenia, gastrointestinal disturbances, hypertension, and bleeding.
## References

[^1]: [[(Home Page) Concise Medical Dictionary 10th Edition by Oxford Reference]]